We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
-8.57%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$3.15B
AUM Growth
+$16.9M
Cap. Flow
-$33.7M
Cap. Flow %
-1.07%
Top 10 Hldgs %
42.21%
Holding
106
New
27
Increased
26
Reduced
18
Closed
18

Top Buys

Rank Stock Value
1
DFPHU
DFP Healthcare Acquisitions Corp. Unit
DFPHU
+$103M
2
VTRS icon
Viatris
VTRS
+$76.6M
3
PCRX icon
Pacira BioSciences
PCRX
+$67.6M
4
BKD icon
Brookdale Senior Living
BKD
+$65.1M
5
ABMD
Abiomed Inc
ABMD
+$62.4M

Top Sells

Rank Stock Value
1
XLRN
Acceleron Pharma
XLRN
+$79.8M
2
RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
+$71.3M
3
TNDM icon
Tandem Diabetes Care
TNDM
+$66.5M
4
HUM icon
Humana
HUM
+$30.1M
5
BOLD
Audentes Therapeutics, Inc
BOLD
+$29.6M

Sector Composition

Rank Sector Weight
1 Healthcare 71.83%
2 Technology 0.07%
3 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ELGX
76
DELISTED
Endologix Inc
ELGX
$656K 0.02%
+950,000
New +$1.16M
SYBX
77
DELISTED
Synlogic
SYBX
$654K 0.02%
+25,353
New +$898K
NEOS
78
DELISTED
Neos Therapeutics, Inc
NEOS
$241K 0.01%
320,993
– –
ZVRA icon
79
Zevra Therapeutics
ZVRA
$578M
$94K ﹤0.01%
26,163
-6,193
-19% -$34.2K
ADUS icon
80
Addus HomeCare
ADUS
$2.22B
– –
-197,915
Closed -$19.2M
ATRC icon
81
AtriCure
ATRC
$2.08B
– –
-292,777
Closed -$9.52M
EHTH icon
82
eHealth
EHTH
$41.9M
– –
-204,000
Closed -$19.6M
HUM icon
83
Humana
HUM
$43.9B
– –
-82,000
Closed -$30.1M
INGN icon
84
Inogen
INGN
$174M
– –
-37,016
Closed -$2.53M
KIDS icon
85
OrthoPediatrics
KIDS
$513M
– –
-225,000
Closed -$10.6M
KOD icon
86
Kodiak Sciences
KOD
$2.5B
– –
-200,000
Closed -$14.4M
TXMD icon
87
TherapeuticsMD
TXMD
$23.8M
– –
-45,000
Closed -$5.45M
XFOR icon
88
X4 Pharmaceuticals
XFOR
$377M
– –
-14,981
Closed -$4.81M
RVNC
89
DELISTED
Revance Therapeutics, Inc.
RVNC
– –
-900,000
Closed -$14.6M
SWAV
90
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
– –
-70,000
Closed -$3.07M
ALPN
91
DELISTED
Alpine Immune Sciences Inc
ALPN
– –
-248,992
Closed -$956K
AERI
92
PUT
DELISTED
Aerie Pharmaceuticals
AERI
– –
-103,800
Closed -$2.51M
GBT
93
DELISTED
Global Blood Therapeutics, Inc.
GBT
– –
-251,000
Closed -$20M
RARX
94
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
– –
-1,519,718
Closed -$71.3M
BOLD
95
DELISTED
Audentes Therapeutics, Inc
BOLD
– –
-493,901
Closed -$29.6M
1 2 3
4

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Deerfield Management's Q1 2020 Portfolio in Review

As of Q1 2020, Deerfield Management held 106 positions worth $3.15B, up 0.54% from $3.13B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Deerfield Management's Q1 2020 filing shows 27 new, 26 increased, 18 reduced and 18 closed positions. Its largest new stake was DFP Healthcare Acquisitions Corp. Unit: 10,460,000 shares worth $103M. The largest sale was Acceleron Pharma, an estimated $79.8M.

By sector, the portfolio is most concentrated in Healthcare at 72% of assets, down from 78% a quarter earlier, followed by Technology and Financials.

  • Deerfield Management's largest Q1 2020 buy was DFP Healthcare Acquisitions Corp. Unit: 10,460,000 shares worth $103M.
  • Deerfield Management added most to Viatris in Q1 2020, an estimated $76.6M increase.
  • Deerfield Management's biggest Q1 2020 reduction was Acceleron Pharma, cutting an estimated $79.8M.
  • Deerfield Management fully exited Ra Pharmaceuticals, Inc. Common Stock in Q1 2020, selling an estimated $71.3M.
  • Deerfield Management's ten largest holdings make up 42% of its $3.15B portfolio in Q1 2020.
  • Deerfield Management opened 27 new positions and closed 18 in Q1 2020.
  • Deerfield Management's portfolio value rose 0.54% quarter-over-quarter to $3.15B.

Based on Deerfield Management's 13F filing for Q1 2020, filed 15 May 2020.